IGMS Insider Trading Activity and SEC Form 4 Filings
IGMS insider trading summary
No open-market insider purchases or sales of IGM Biosciences, Inc. (IGMS) have been reported on SEC Form 4 in the past 12 months.
Latest IGMS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 23, 2025 | Lisa Lynn Decker | Chief Business Officer | Sell | $6K (4,409 @ $1.27) |
| Jul 23, 2025 | Mary Beth Harler | Chief Executive Officer | Sell | $18K (14,501 @ $1.27) |
| Jul 23, 2025 | Misbah Tahir | Chief Financial Officer | Sell | $11K (8,741 @ $1.27) |
| Jun 16, 2025 | Misbah Tahir | Chief Financial Officer | Sell | $2K (1,522 @ $1.20) |
| Jun 16, 2025 | Lisa Lynn Decker | Chief Business Officer | Sell | $1K (951 @ $1.20) |
| Jun 16, 2025 | Mary Beth Harler | Chief Executive Officer | Sell | $2K (1,522 @ $1.20) |
| Jun 16, 2025 | Steven Weber | Principal Accounting Officer | Sell | $583 (486 @ $1.20) |
| May 14, 2025 | Steven Weber | Principal Accounting Officer | Sell | $2K (1,865 @ $1.12) |
| Mar 14, 2025 | Mary Beth Harler | Chief Executive Officer | Sell | $9K (7,329 @ $1.23) |
| Mar 14, 2025 | Misbah Tahir | Chief Financial Officer | Sell | $9K (7,329 @ $1.23) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.